Background:
Data are scarce about short-term right ventricular changes in pulmonary hypertension. Two-dimensional knowledge-based reconstruction of the right ventricle with 2D echocardiography (2DKBR) has been shown to be a valid alternative to Cardiac MRI.
Patients and Methods:
In this longitudinal study 25 pulmonary hypertension patients underwent 2DKBR of the right ventricle, assessment of NT-proBNP levels and functional class at baseline and after a mean follow-up of 6.1 months. Patients were followed up clinically for a further mean of 8.2 months. The majority of patients had connective tissue disease (CTD) associated pulmonary arterial hypertension (n=15) or chronic thromboembolic pulmonary hypertension (CTEPH; n=6). A total of 15 patients underwent an intervention, either new targeted therapy, escalation of targeted therapy or pulmonary endarterectomy. A total of 10 clinically stable patients were routinely followed up without any change in therapy.
Results: There were significant improvements in the right ventricular end-diastolic volume index (111±29 mL/m² vs 100±36 mL/m²; P=.038), end-systolic volume index (72±23 mL/m² vs 61±25 mL/m²; P=.001), and ejection fraction (35±10% vs 40±9%;
P=.030).
Changes in NT-proBNP levels correlated strongest with changes in endsystolic volume index (r=−.77; P=<.0001). Four patients experienced clinical worsening during extended follow-up, dilatation of the right ventricle was associated with clinical worsening.
Conclusion:
In a CTD and CTEPH dominated patient population significant reverse remodeling and improvement of ejection fraction occurred despite a short follow-up and was paralleled by significant changes in NT-proBNP levels. Further right ventricular dilatation was associated with worse clinical outcome. 2DKBR is a feasible substitute for Cardiac MRI to follow-up right ventricular indices in pulmonary hypertension.
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| INTRODUCTION
Pulmonary hypertension leads to pressure overload of the right ventricle, which causes hypertrophy and eventual failure of the right ventricle. In terms of symptoms and prognosis right ventricular function is the main determinant. 1, 2 2D echocardiography, the most widely available cardiac imaging modality has significant limitations due to the unique crescent shape of the right ventricle. 3 Both linear and right ventricular area measurements can be challenging and can significantly underestimate true right ventricular size. 4 Also, parameters of systolic function assessed with 2D echocardiography showed only moderate correlation in several studies. 5, 6 Cardiac magnetic resonance (CMR) imaging has evolved as the gold standard for imaging of the right ventricle, 7 and studies have suggested that both changes in volumes and ejection fraction [8] [9] [10] predict outcome in pulmonary hypertension. However, CMR is costly, resource intensive and not widely available in low-income countries, which makes it less suitable for serial short-term follow-up. Also, CMR is contraindicated in many patients with implanted ferromagnetic devices. Commercially available 3D echocardiography has been compared to CMR; however, this technique exhibits only moderate reproducibility of right ventricular volumes and ejection fraction 11 and exhibits a negative bias in ejection fraction and volumes. 12 We and others have compared 2D echocardiography knowledgebased reconstruction (2DKBR) of the right ventricle to CMR for volumetric quantification in pulmonary hypertension demonstrating good inter-and intra-observer reproducibility. 5, 13 Feasibility of this method was also demonstrated in other studies, [14] [15] [16] and it is licensed for clinical use in the United Kingdom.
Data are scare about change in right ventricular indices during periods of less than 12 months in pulmonary hypertension. In this study, we describe the use of short-term serial 2DKBR to evaluate change in right ventricular indices in a mixed PH population, which was dominated by pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD) and chronic thromboembolic pulmonary hypertension (CTEPH).
| PATIENTS AND METHODS

| Patients
We performed an observational and longitudinal study that involved 25 patients with pulmonary hypertension. Participants underwent 2D echocardiography and 2DKBR of the right ventricle as well as assessment of 6-minute walking test (6MWT) results, NT-proBNP levels, and functional class both at baseline and after a mean follow-up of 6.1±3 months.
All incident patients and patients that had augmentation of disease targeted therapy underwent right heart catheterization within 2 weeks of echocardiography (usually on the same day) as per national guidelines.
All echocardiograms were performed by the first author. Median/interquartile range similar to NT-proBNP levels in Table 2 .
routine clinical work. The VMS system (Ventripoint Diagnostics Ltd., Seattle, WA, USA) is a registered trademark and licensed for use in the United Kingdom.
| Follow-up
All patients were clinically followed for a mean of 8.2±3.1 months after the second 2DKBR echocardiogram including assessment of NTproBNP levels and functional class. Clinical worsening was defined as death secondary to pulmonary hypertension or a mandatory combination of four factors: persistent functional class III (or worsening to functional class III/IV), an increase in NT-proBNP levels since last evaluation, a NT-proBNP level of at least 100 pmol/L, and an unplanned increase in targeted therapy.
| Methods
| Echocardiography
Transthoracic echocardiographic images were acquired using standard ultrasound equipment (Philips iE33 and S5 transducer, Philips Medical Systems, Andover, MA, USA) following current guidelines. 17, 18 For 2DKBR, we used the VMS system (Ventripoint Diagnostics Ltd., Seattle, WA, USA) as previously described. 5 In brief, a 3D right ventricular (RV) volume is generated from 2DE-acquired coordinates localized in 3D space that are then connected by reference to a library of disease-specific RV shapes (hybrid approach). A magnetic localizer was attached to the S5-1 probe, which detects orthogonal magnetic fields from a generator hanging over the patient and allows localization at the point of any 2D acquisition in 3D space.
Seven views were obtained, six of which are standard 2D echocardiographic views, one view an off-axis RV apical view. After visual identification of the end-diastolic and end-systolic frames in fourchamber view predefined points were plotted for each end-diastolic and end-systolic datasets. These coordinates of these landmarks were then submitted via Internet to a remote server for processing by a proprietary 2DKBR algorithm. The algorithm interpolates between the plotted points by referencing against a catalog of RV shapes generated by CMR imaging from patients with a known diagnosis of pulmonary hypertension.
During postprocessing intersections between the borders of the 3D model and the original 2D scan plane were checked for alignment, and in case of significant deviation either re-plotted or the algorithm rerun. Right ventricular end-diastolic volume index (RV-EDVI), endsystolic volume index (RV-ESVI), ejection fraction (RV-EF), and stroke volume index (RV-SVI) were calculated. A dataset was excluded if more than one slice was unsuitable for analysis.
As a case example, Figure 1 demonstrates results of 2D and 2DKBR echocardiography both at baseline and follow-up of a 70-year-old male patient with limited cutaneous systemic sclerosis of 10-year duration. These demonstrate significant RV reverse remodeling and improvement of ejection fraction after receiving combination targeted treatment of 4.5 months compared to baseline studies.
| Right heart catheterization
Right heart catheterization was performed according to national guidelines. The following pressures were obtained: right atrium, pulmonary artery, and pulmonary capillary wedge pressure. Cardiac output was determined with the Thermodilution Method. Mixed venous saturations were taken in pulmonary artery, and systemic oxygen saturation was obtained with finger oximetry.
| Laboratory testing
For measurement of NT-proBNP levels, venous blood samples were either collected at the end of right heart catheterization or during follow-up visits in outpatient clinic and processed at the laboratory of the Royal Free Hospital.
| Statistics
Statistical analysis was performed using SPSS 21.0 (IBM Corporation,
Armonk, NY, USA). Kolmogorov-Smirnov tests (Lilliefors correction)
were used to test for normal distribution of variables. Comparison of continuous variables at baseline and follow-up was performed using paired t tests or related-samples Wilcoxon signed-rank test in the case of NT-proBNP, which was not normally distributed. Spearman's correlations were performed to calculate correlation coefficients for NT-proBNP, for graphical presentation of correlation of changes in NT-proBNP levels, and right ventricular indices levels were logarithmically transformed before calculation. 
| RESULTS
| Correlation of NT-proBNP levels with RV indices
At baseline NT-proBNP levels were significantly correlated with 
| Outcome
Three follow-up of 8.2±3.1 months (Table 3) . Multivariate analysis was not performed due to small number of patients.
| DISCUSSION
In technique to be accurate and reproducible 5, 13, 15, 16 In this study, we have used it in a busy clinical setting.
Follow-up data of less than 12 months are scarce in pulmonary hypertension, and our study offers some insight into short-term right ventricular changes in this population. In CTEPH imaging studies offering short-term follow-up are available and have demonstrated regression of RV remodeling after PEA or Balloon pulmonary angioplasty. [19] [20] [21] [22] In IPAH, associated PAH or mixed PAH populations the situation is different, data are scarce about short-term follow-up of less than 12 months.
One 2D-echo study demonstrated improvement of RV dimensions and parameters of RV-function after 1 year of treatment with prostacyclin 
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31±9 ( . The right ventricles in this study were mildly enlarged, and only a minority of patients were on prostanoid therapy (5%) or on combination therapy (9.9%).
Factors that may influence the ability to document reverse remodeling of the RV include the following: the characteristics of the pulmonary vascular disease, the presence of RV dilatation at the time of the treatment initiation, and the magnitude and effect of therapy.
In contrast to above mentioned studies, our patient population was dominated by CTD-PAH and CTEPH with virtually no IPAH patients. CTD-associated PAH differs from IPAH in its clinical course 24, 25 and also in its histological appearance. 26 NT-proBNP level is higher at diagnosis despite similar hemodynamics 27 indicating a poorer tolerance of PH than other forms of PAH. 28, 29 This, however, could also favor a larger change in RV indices as a response to aggressive therapy, at least in the short term. This would be supported by recent evidence that CTD-associated and systemic sclerosis-associated PAH patients benefit from aggressive PAH-targeted treatment. 30 Secondly, in our population, RV volumes were significantly more dilated at baseline in comparison with above mentioned studies. Ventricular remodeling in PAH can be differentiated into two patterns 31, 32 : adaptive remodeling with concentric hypertrophy, preserved function, and maladaptive remodeling with eccentric hypertrophy and worsening function. Our study shows that within several months a change from one pattern to the other can occur with medical therapy, even in CTD-associated PAH.
NT-proBNP is a known prognostic marker in pulmonary hypertension. [33] [34] [35] In line with other investigators, we found a modest correlation between RV volumetric indices and NT-proBNP levels. [36] [37] [38] This is not surprising as wall stress modulates BNP gene expression, 39, 40 and one of the main determinants of wall stress is end-diastolic volume. However, when tracking changes over time, we have seen that changes in NT-proBNP levels were closely related to changes in both RV volumes and RV-ejection fraction, strongest however with changes end-systolic volume. In a similar study by Gan et al., changes in NTproBNP levels significantly correlated with change in right ventricular volume, the strongest correlation was seen with changes in right ventricular ejection fraction. There are several notable differences in patient selection compared to our study, which help explaining the difference in findings. 38 Gan et al. studied a population, which was dominated by IPAH, and patients had relatively preserved right ventricular end-diastolic indices. Despite treatment there was further RV enlargement and increase in NT-proBNP levels in half of the patients.
The findings of these two studies could be interpreted that in adaptive response to pressure overload changes in NT-proBNP levels mainly reflect changes in RV-ejection fraction, whereas in maladaptive response they more reflect changes in RV volume. Analogies can be drawn to other diseases where significant remodeling takes place.
In ischemic mitral regurgitation, left ventricular end-systolic volume is a stronger predictor of outcome than ejection fraction 41 and also in a population with atrial septal defects and significant RV dilatation, and it has been found that NT-proBNP correlates more strongly with RV-ESVI than with RV-EF. 42 We have clinically followed patients for a further 8.3 months and observed that remodeling of RV volumes was associated with clinical worsening. We have not performed multivariate analysis due to limited number of patients, however, have used stringent criteria for clinical worsening, and these results confirm those of larger and longer outcome studies. Van Veerdonk et al. 9 have demonstrated increasing RV-EDVI and RV-ESVI were the follow-up variables most significantly associated with mortality in a follow-up of 47 months. van Wolferen et al. 8 also showed that RV dilatation independently predicted outcome during a follow-up of 32 months, and other imaging studies have identified RV dilatation as a marker for poor prognosis in IPAH as well. 43, 44 Limitations of our study are that this was an observational study, and our single-center study population is small. Larger studies are needed, in particular in CTD-associated PAH to better define right ventricular geometry in this unique subpopulation within the PAH subgroup. All echocardiograms were performed by a single person, which may limit generalizability; however, there was no significant intra-and inter-observer test-retest variability for right ventricular volumes in a recent validation study of 2DKBR. 
| CONCLUSIONS
In a CTD-PAH and CTEPH dominated patient population significant reverse remodeling and improvement of ejection fraction occurred T A B L E 3 Association of changes in RV indices and NT-proBNP levels with adverse events despite a relatively short follow-up, which is likely to be associated with an improvement in prognosis based on a strong association with changes of NT-proBNP values. Further RV dilatation was associated with worse clinical outcome. 2DKBR can be reliably used in a busy clinical setting to follow-up right ventricular indices in pulmonary hypertension, for example, parallel to right heart catheterization.
